Randomized Controlled Trial

Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial.

Lancet Oncol. 2014 Jul 1; 15 (8): 829840829-40.
Comparative Study

Comparative outcomes between initially unresectable and recurrent cases of advanced pancreatic cancer following palliative chemotherapy.

Pancreas. 2014 Apr 1;43(3):411-6.
Article

Neutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patients.

Cancer Med. 2014 Apr 1;3(2):406-15.